Increased concentrations of transforming growth factor β1 and β2 in the plasma of patients with glioblastoma

Journal of Neuro-Oncology

Volumn 79, Issue 1, 2006, Pages 61-65

  Schneider, Thomas ^a   Sailer, Michael ^a   Ansorge, Siegfried ^b   Firsching, Raimund ^a   Reinhold, Dirk ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b IMTM GmbH   (Germany)

Author keywords

Glioblastoma; Plasma concentrations; TGF 1; TGF 2

Indexed keywords

DEXAMETHASONE; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRAIN SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLIOBLASTOMA; HUMAN; IN VIVO STUDY; MALE; MICROSURGERY; MULTIPLE SCLEROSIS; PROPORTIONAL HAZARDS MODEL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; STEREOTAXIC SURGERY; SURVIVAL TIME; THROMBOCYTE POOR PLASMA;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; POSTOPERATIVE PERIOD; SURVIVAL ANALYSIS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TUMOR MARKERS, BIOLOGICAL;

EID: 33745962224     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-005-9116-7     Document Type: Article

References (33)

1. Brooks W, Netsky MG, Normansell DE, Horwitz DA: Depressed cell mediated immunity in patients with primary intracranial tumors J Exp Med 136: 1631-1647, 1972
2. Kuppner MC, Hamou MF, Sawamura Y, Bodmer S, de Tribolet N: Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2 J Neurosurg 71: 211-217, 1989
3. Darley R, Morris A, Passas J, Bateman W: Interactions between interferon γ and retinoic acid with transforming growth factor β in the induction of immune recognition molecules Cancer Immunol Immunother 37: 112-118, 1993
4. Fontana A, Constam DB, Frei K, Malipiero U, Pfister HW: Modulation of the immune response by transforming growth factor beta Int Arch Allergy Immunol 99: 1-7, 1992
5. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew SB, Alvarez-Mon M, Derynck R, Sporn MB, Fauci AS: Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth J Exp Med 163: 1037-1050, 1986
6. Kehrl JH, Roberts AB, Wakefield LM, Jakowlew SB, Sporn MB, Fauci AS: Transforming growth factor beta is an important immunomodulatory protein for human B-lymphocytes J Immunol 137: 3855-3860, 1986
7. Maxwell M, Galanopoulos T, Neville-Golden J, Antoniades HN: Effect of the expression of transforming growth factor-β2 in primary human glioblastomas on immunosuppression and loss of immune surveillance J Neurosurg 76: 799-804, 1992
8. Roberts AB, Sporn MB: The transforming growth factor-βs. In: Sporn MB, Roberts AB (eds) Peptide Growth Factors and Their Receptors (Handbook of Experimental Pharmacology). Springer Verlag, Heidelberg, 1990, Vol 95, pp 419-472
9. Fontana A, Bodmer S, Frei K, Malipiero U, Siepl C: Expression of TGF-beta 2 in human glioblastoma: A role in resistance to immune rejection? Ciba Found Symp 157: 232-238, 1991
10. Bodmer S, Strommer K, Frei K, Siepl C, de Tribolet N, Heid I, Fontana A: Immunosuppression and transforming growth factor-β in glioblastoma. Preferential production of transforming growth factor-β 2 J Immunol 143: 3222-3229, 1989
11. Jachimczak P, Hessdörder B, Fabel-Schulte K, Wismeth C, Brysch W, Schlingensiepen K-H, Bauer A, Blesch A, Bogdahn U: Transforming growth factor-β-mediated autocrine growth regulation of gliomas as detected with phosphorothioate antisense oligonucleotides Int J Cancer 65: 332-337, 1996
12. Tada T, Yabu K, Kobayashi S: Detection of active form of transforming growth factor-β in cerebrospinal fluid of patients with glioma Jpn J Cancer Res 84: 544-548, 1993
13. Bodmer S, Huber D, Heid I, Fontana A: Human glioblastoma cell derived transforming growth factor-beta 2: Evidence for secretion of both high and low molecular weight biologically active forms J Neuroimmunol 34: 33-42, 1991
14. Reinhold D, Bank U, Bühling F, Junker U, Kekow J, Schleicher E, Ansorge S: A detailed protocol for the measurement of TGF-β1 in human blood samples J Immunol Methods 209: 203-206, 1997
15. Danielpour D: Improved sandwich enzyme-linked immunosorbent assays for transforming growth factor β1. J Immunol Methods 158: 17-25, 1993
16. Szymkowiak CM, Mons J, Gross WL, Kekow J: Determination of transforming growth factor β2 in human blood samples by ELISA J Immunol Methods 184: 263-271, 1995
17. Kekow J, Wachsman W, Mc Cutchan JA, Gross WL, Zachariah M, Carson DA, Lotz M: Tranforming growth factor β and suppression of humoral immune response in HIV infection J Clin Invest 87: 1010-1016, 1991
18. Constam DB, Philipp J, Malipiero UV, ten Dijke P, Schachner M, Fontana A: Differential expression of transforming growth factor-β 1, -β 2, and -β 3 by glioblastoma cells, astrocytes, and microglia J Immunol 148: 1404-1410, 1992
19. Helseth E, Unsgaard G, Dalen A, Vik R: The effect of type beta transforming growth factor on proliferation of clonogenic cells from human gliomas Acta Neurochir Suppl Wien 43: 118-120, 1988
20. Olofsson A, Miyazono K, Kanzaki T, Colosetti P, Engstrom U, Heldin CH: Transforming growth factor-beta 1, -beta 2, and -beta 3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes J Biol Chem 267: 19482-19488, 1992
21. Sasaki A, Naganuma H, Satoh E, Nagasaka M, Isoe S, Nakano S, Nukui H: Secretion of transforming growth factor-beta 1 and -beta 2 by malignant glioma cells Neurol Med Chir Tokyo 35: 423-430, 1995
22. Gridley DS, Loredo LN, Slater JD, Archambeau JO, Bedros AA, Andres ML, Slater JM: Pilot evaluation of cytokine levels in patients undergoing radiotherapy for brain tumor Cancer Detect Prev 22: 20-29, 1998
23. Hulshof MC, Sminia P, Barten-Van Rijbroek AD, Gonzalez GD: Prognostic value of plasma transforming growth factor-beta in patients with glioblastoma multiforme Oncol Rep 8: 1107-1110, 2001
24. Peterson PK, Chao CC, Hu S, Thielen K, Shaskan EG: Glioblastoma, transforming growth factor-beta, and Candida meningitis: A potential link Am J Med 92: 262-264, 1992
25. Ruffini PA, Rivoltini L, Silvani A, Boiardi A, Parmiani G: Factors, including transforming growth factor, released in the glioblastoma residual cavity, impair activity of adherent lymphokine-activated killer cells Cancer Immunol Immunother 36: 409-416, 1993
26. Sablotzki A, Ebel H, Muhling J, Dehne MG, Nopens H, Giesselmann H, Hempelmann G: Dysregulation of immune response following neurosurgical operations Acta Anaesthesiol Scand 44: 82-87, 2000
27. Couldwell WT, Dore-Duffy P, Apuzzo MLJ, Antel JP: Malignant glioma modulation of immune function: Relative contribution of different soluble factors J Immunol 33: 89-96, 1991
28. Naganuma H, Sasaki A, Satoh E, Sakihama T, Tasaka K, Nukui H: Improved bioassay for the detection of transforming growth factor-β 1 and β 2 in malignant gliomas Neurol Med Chir (Tokyo) 34: 143-149, 1994
29. Huber D, Philipp J, Fontana A: Protease inhibitors interfere with the transforming growth factor-β-dependent but not the transforming growth factor-β-independent pathway of tumor cell-mediated immunosuppression J Immunol 148: 277-284, 1992
30. Lyons RM, Keski-Oja J, Moses HL: Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium J Cell Biol 106: 1659-1665, 1988
31. Miyazono K, Heldin CH: Role for carbohydrate structures in TGF-β1 latency Nature 338: 158-160, 1989
32. Szymkowiak CH, Csernok E, Reinhold D, Bank U, Gross WL, Kekow J: Neutrophils synthesize and activate TGFbeta2 Cytokine 12: 397-400, 2000
33. Nazzarro JM, Neuwelt EA: The role of surgery in the managament of supratentorial intermediate and high grade astrocytoma in adults J Neurosurg 72: 408-417, 1990